A soluble form of CTLA‐4 generated by alternative splicing is expressed by nonstimulated human T cells
CTLA‐4, expressed by activated T cells, transduces an inhibitory signal. We show here that PCR amplification of the coding sequence of CTLA‐4 in nonstimulated human T lymphocytes results in the amplification of two transcripts of 650 and 550 bp. Sequencing shows that the larger form codes for membra...
Saved in:
Published in | European journal of immunology Vol. 29; no. 11; pp. 3596 - 3602 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY‐VCH Verlag GmbH
01.11.1999
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | CTLA‐4, expressed by activated T cells, transduces an inhibitory signal. We show here that PCR amplification of the coding sequence of CTLA‐4 in nonstimulated human T lymphocytes results in the amplification of two transcripts of 650 and 550 bp. Sequencing shows that the larger form codes for membrane CTLA‐4 and the 550‐bp transcript is a spliced variant in which exon 2 coding for the transmembrane region is deleted. This spliced cDNA has been named CTLA‐4delTM. The splicing induces a frame shift which results in the addition of 22 extra amino acids before a translational termination. Activation of T cells with phorbol 12‐myristate 13‐acetate plus ionomycin or anti‐CD3 plus anti‐CD28 monoclonal antibodies induces a suppression of CTLA‐4delTM mRNA expression associated with a preferential expression of the membrane CTLA‐4 mRNA, showing that CTLA‐4delTM mRNA expression is restricted to nonactivated T cells. A soluble immunoreactive form of CTLA‐4 was detected in the serum of 14 / 64 healthy subjects. These results suggest that nonstimulated T cells may constitutively produce a soluble form of CTLA‐4 which may have an important role in the regulation of immune homeostasis. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0014-2980 1521-4141 |
DOI: | 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y |